ما هو علاج الفشل التنفسي الحاد؟ أهداف الأكسجة والدعم التنفسي

References

DOI: 10.1186/s40560-023-00658-3

• In ARF, the choice between the use of nasal cannula, HFNC, NPPV, or invasive positive pressure ventilation (IPPV) is based on the presence of underlying disease and severity of hypoxemia.
• In the HFNC guidelines by the American College of Physicians, HFNC was weakly recommended for ARF over NPPV due to a systematic review reporting that HFNC for ARF is associated with lower mortality and a lower intubation rate compared to NPPV.
• Based on this evidence, the JRS/JSICM/JSRCM-GL2021 and FICM/ICS-GL 2018 weakly recommend restrictive fluid management.
• In ARF, pharmacotherapy should be focused on the underlying disease or diseases that are causing hypoxemia.
• PaO2 was maintained between 70 and 110 mmHg in both groups in all studies.